Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07091032 · ClinicalTrials.gov registry record · NA

Building Connections

A NA study of Obesity and Depression, Anxiety, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
3,600
Enrollment target
1
Study location

NCT07091032 is a NA study of Obesity and Depression, Anxiety that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 3,600 participants, above the 816-participant average among 1,053 other Obesity trials with a reported enrollment target (341% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07091032, a NA study of Obesity and Depression, Anxiety, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
3,600 participants
Enrollment target
1
Study location

Study Summary

Building Connections seeks to address health and healthcare inequities in socially vulnerable communities. The project will be conducted in collaboration with clinical practices across Massachusetts, serving a diverse population heavily represented in Community Clinics and Health Centers. The program will offer evidence-based interventions in obesity/weight management, cancer screening, and mental health.

Interventions

  • OTHER Treatment as Usual
  • BEHAVIORAL Building Connections Intervention

Study Locations (1)

Massachusetts

  • Disparities Research Unit, Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 3,600 participants
Start Date 2025-08-07
Est. Completion 2029-12-30
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT07091032

The ClinicalTrials.gov registry entry for NCT07091032 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 3,600 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 816-participant average among 1,053 other Obesity trials with a reported enrollment target (341% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.

NCT07091032 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07091032 about?

NCT07091032 is a clinical study titled "Building Connections". Building Connections seeks to address health and healthcare inequities in socially vulnerable communities. The project will be conducted in collaboration with clinical practices across Massachusetts, serving a diverse population heavily represented in Community Clinics and Health Centers. The progra...

What is the current status of trial NCT07091032?

This trial is currently recruiting. It is a NA study. The enrollment target is 3,600 participants. The study started on 2025-08-07. Estimated completion is 2029-12-30.

What conditions does trial NCT07091032 study?

This clinical trial studies the following conditions: Obesity, Depression, Anxiety, Cancer Colorectal, Cancer Cervix.

What interventions are being tested in trial NCT07091032?

The interventions under investigation include: Treatment as Usual (OTHER), Building Connections Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07091032?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07091032 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.